Literature DB >> 12610170

Carcinomatosis--is cure an option?

Paul H Sugarbaker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12610170     DOI： 10.1200/JCO.2003.12.071

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  10 in total

1.  High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis.

Authors:  Philippe Esquis; David Consolo; Guy Magnin; Philippe Pointaire; Philippe Moretto; Maria Dolores Ynsa; Jean-Luc Beltramo; Carole Drogoul; Michel Simonet; Laurent Benoit; Patrick Rat; Bruno Chauffert
Journal:  Ann Surg       Date:  2006-07       Impact factor: 12.969

Review 2.  Current status and future prospects of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) clinical trials in ovarian cancer.

Authors:  Renee A Cowan; Roisin E O'Cearbhaill; Oliver Zivanovic; Dennis S Chi
Journal:  Int J Hyperthermia       Date:  2017-08       Impact factor: 3.914

3.  Distribution pattern and penetration depth of doxorubicin after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a postmortem swine model.

Authors:  Veria Khosrawipour; Tanja Khosrawipour; Alexander Jens Peter Kern; Aras Osma; Burak Kabakci; David Diaz-Carballo; Eckart Förster; Jürgen Zieren; Khashayar Fakhrian
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-02       Impact factor: 4.553

4.  Surgical management of carcinomatosis from colorectal cancer.

Authors:  Paul H Sugarbaker
Journal:  Clin Colon Rectal Surg       Date:  2005-08

5.  Multimodality treatment of peritoneal carcinomatosis from colorectal cancer: first results of a new German centre for peritoneal surface malignancies.

Authors:  P Piso; M H Dahlke; N Ghali; I Iesalnieks; M Loss; F Popp; P von Breitenbuch; A Agha; S A Lang; F Kullmann; H J Schlitt
Journal:  Int J Colorectal Dis       Date:  2007-04-26       Impact factor: 2.571

6.  Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancer.

Authors:  Jason J Hall; Brian W Loggie; Perry Shen; Staci Beamer; L Douglas Case; Richard McQuellon; Kim R Geisinger; Edward A Levine
Journal:  J Gastrointest Surg       Date:  2004 May-Jun       Impact factor: 3.452

7.  Peritoneal carcinomatosis of colorectal origin: Incidence, prognosis and treatment options.

Authors:  Yvonne L B Klaver; Valery E P P Lemmens; Simon W Nienhuijs; Misha D P Luyer; Ignace H J T de Hingh
Journal:  World J Gastroenterol       Date:  2012-10-21       Impact factor: 5.742

8.  Selection of patients with ovarian cancer who may show survival benefit from hyperthermic intraperitoneal chemotherapy: A systematic review and meta-analysis.

Authors:  Se Ik Kim; Jaehyun Cho; Eun Ji Lee; Sunwoo Park; Soo Jin Park; Aeran Seol; Nara Lee; Ga Won Yim; Maria Lee; Whasun Lim; Gwonhwa Song; Suk Joon Chang; Jae Won Kim; Hee Seung Kim
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.817

9.  Comparison of the Peritoneal Cancer Index and Dutch region count as tools to stage patients with peritoneal metastases of colorectal cancer.

Authors:  F S Verheij; C Bakkers; W J van Eden; A G J Aalbers; S W Nienhuijs; K Jóźwiak; I H J T de Hingh; N F M Kok
Journal:  BJS Open       Date:  2020-06-23

10.  Effect of Irradiation on Tissue Penetration Depth of Doxorubicin after Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) in a Novel Ex-Vivo Model.

Authors:  Veria Khosrawipour; Urs Giger-Pabst; Tanja Khosrawipour; Yousef Hedayat Pour; David Diaz-Carballo; Eckart Förster; Hugo Böse-Ribeiro; Irenäus Anton Adamietz; Jürgen Zieren; Khashayar Fakhrian
Journal:  J Cancer       Date:  2016-05-07       Impact factor: 4.207
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.